# Effect of Two Different Dosages of Ethinyl-estradiol in Association With Drospirenone in Women With Polycystic Ovary Syndrome.

> **NCT01519401** · NA · COMPLETED · sponsor: **Catholic University of the Sacred Heart** · enrollment: 50 (actual)

## Conditions studied

- Polycystic Ovary Syndrome
- Estro-progestin Drugs

## Interventions

- **DRUG:** 3 mg drospirenone and 20 µg ethinyl-estradiol
- **DRUG:** 3 mg drospirenone and 30 µg ethinyl-estradiol

## Key facts

- **NCT ID:** NCT01519401
- **Lead sponsor:** Catholic University of the Sacred Heart
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-02
- **Primary completion:** 2011-07
- **Final completion:** 2011-07
- **Target enrollment:** 50 (ACTUAL)
- **Last updated:** 2020-07-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01519401

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01519401, "Effect of Two Different Dosages of Ethinyl-estradiol in Association With Drospirenone in Women With Polycystic Ovary Syndrome.". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01519401. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*